Patents by Inventor Cyrille HOARAU

Cyrille HOARAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL HUMAN THERAPEUTIC MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20230203197
    Abstract: New human therapeutic monoclonal antibodies, which are directed against neutrophil proteinase 3. The monoclonal antibodies are specifically directed against a conformational epitope of the neutrophil proteinase 3 and are capable of inhibiting by at least 30% the production for reactive oxygen derivatives by neutrophils. Also, a pharmaceutical composition including as an active substance at least the monoclonal antibody, and a method for early treatment and/or prevention of relapse of granulomatosis with polyangiitis, which includes the administration of the pharmaceutical composition.
    Type: Application
    Filed: October 16, 2020
    Publication date: June 29, 2023
    Applicants: UNIVERSITE DE TOUR, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Roxane LEMOINE, Cyrille HOARAU, Eric MORELLO, Brice KORKMAZ, Yann GALLAIS